KIR genes and their role in spondyloarthropathies

Advances in Experimental Medicine and Biology

Volumn 649, Issue , 2009, Pages 286-299

  Díaz Peña, Roberto ^a   Blanco Gelaz, Miguel Ángel ^a   López Larrea, Carlos ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA B27 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; HLA ANTIGEN CLASS 1; LIGAND;

ANKYLOSING SPONDYLITIS; ARTICLE; CELL SURFACE; DISEASE ASSOCIATION; GENE CLUSTER; GENE FUNCTION; GENE LOCATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN GENE; IMMUNOPATHOGENESIS; KILLER IMMUNOGLOBULIN LIKE RECEPTOR GENE; MOLECULAR DYNAMICS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN STRUCTURE; PSORIATIC ARTHRITIS; SIGNAL TRANSDUCTION; SPONDYLOARTHROPATHY; T LYMPHOCYTE SUBPOPULATION; ALLELE; GENETICS; IMMUNOLOGY; REVIEW;

ALLELES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B27 ANTIGEN; HUMANS; LIGANDS; RECEPTORS, KIR; SPONDYLARTHROPATHIES;

EID: 70349580518     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-0298-6_22     Document Type: Article

References (78)

1. French RA, Yokoyama WM. Natural killer cells and autoimmunity. Arthritis Res Ther 2004: 6(1):8-14. (Pubitemid 38256082)
2. Ljunggren HG, Kärre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990: 11(7):237-44. (Pubitemid 20198988)
3. Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23:225-74. (Pubitemid 40563170)
4. Khakoo SI, Carrington M. KIR and disease: A model system or system of models? Immunol Rev 2006: 214:186-201. (Pubitemid 44707911)
5. Williams AP, Bateman AR, Khakoo SI. Hanging in the balance. KIR and their role in disease. Mol Interv 2005: 5(4):226-40. (Pubitemid 41242129)
6. Brewerton DA, Hart FD, Nicholls A et al. Ankylosing spondylitis and HL-A 27. Lancet 1973: 1(7809):904-7.
7. Brewerton DA, Caffrey M, Nicholls A et al. Reiter's disease and HL-A 27. Lancet 1973: 2(7836):996-8.
8. Schlosstein L, Terasaki PI, Bluestone R et al. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973: 288(14):704-6.
9. Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990; 11(4):137-42.
10. Kollnberger S, Chan A, Sun MY et al. Interaction of HLA-B27 homodimers with KIR3DLl and KIR3DL2, unlike HLA-B27 hererotrimers, is independent of the sequence of bound peptide. Eur J Immunol 2007; 37(5):1313-22. (Pubitemid 46925315)
11. Azuz-Lieberrnan N, Markel G, Mizrahi S et al. The involvement of NK cells in ankylosing spondylitis. Int Immunol 2005: 17(7):837-45. (Pubitemid 41417951)
12. Lanier LL, Corliss BC, Wu Jet al. Immunorecepror DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 1998; 391(6668):703-7. (Pubitemid 28113218)
13. Olcese L, Cambiaggi A, Sernenzato G et al. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol 1997, 158(11):5083-6. (Pubitemid 127681207)
14. Kikuchi-Maki A, Carina TL, Campbell KS. Cutting edge: KIR2DL4 transduces signals into human NK cells through association with the Fc receptor gamma protein. J Immunol 2005, 174(7):3859-63. (Pubitemid 40395957)
15. Shilling HG, Guethlein LA, Cheng NW et al. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol 2002; 168(5):2307-15. (Pubitemid 34171832)
16. Hsu KC, Chida S, Geraghty DE et al. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002; 190:40-52. (Pubitemid 36071925)
17. Uhrberg M, Parham P, Wernet P. Definition of gene content for nine common group B haplotypes of the caucasoid population: KIR haplotypes contain between sevenand eleven KIR genes. Immunogenetics 2002; 54(4):221-9. (Pubitemid 34824132)
18. Norman PJ, Carrington CV, Byng M et al. Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in african and south asian populations. Genes Immun 2002; 3(2):86-95. (Pubitemid 38961114)
19. Jiang K, Zhu FM, Lv QF er al. Distribut ion of killer cell immunoglobulin-like receptor genes in the chinese han population. Tissue Antigens 2005; 65(6):556-63. (Pubitemid 40776305)
20. Parham P. MHC class 1 molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005; 5(3):201-14. (Pubitemid 40364822)
21. Yawata M, Yawata N, Moqueen KL et al. Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expresion, Immunogenetics 2002, 54(8):543-50. (Pubitemid 35435512)
22. Toneva M, Lepage V, Lafay G et al. Genomic diversity of natural killer cell receptor genes in three populations. Tissue Antigens 2001, 57(4):358-62. (Pubitemid 32511307)
23. Gardiner CM, Guethlein LA, Shilling HG et al. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 2001; 166(5):2992-3001. (Pubitemid 33117294)
24. *004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol 2003; 171(12):6640-9. (Pubitemid 37532096)
25. Yawata M, Yawata N, Draghi M et al. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 2006, 203(3):633-45.
26. Anfossi N, Doisne JM, Peyrat MA et al. Coordinated expressionof Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T-cells. J Immunol 2004, 173(12):7223-9. (Pubitemid 39628158)
27. Rajagopalan S, Long EO. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 1999; 189(7):1093-100.
28. Cella M, Longo A, Ferrara GB et al. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 1994; 180(4):1235-42.
29. Carr WH, Rosen DB, Arase H et al. Cutting edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J Immunol 2007; 178(2):647-51. (Pubitemid 46095135)
30. Gumperz JE, Barber LD, Valiance NM et al. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKBI killer cell-inhibitory receptor. J Immunol 1997; 158(11):5237-41. (Pubitemid 127681227)
31. Boyington JC, Motyka SA, Schuck P et al. Crystal Structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 2000, 405(6786):537-43.
32. Fan QR, Long EO, Wiley DC. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol 2001; 2(5):452-60. (Pubitemid 33706144)
33. Rajagopalan S, Long EO. The direct bind ing of a p58 killer cell inhibitory receptOr to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med 1997; 185(8):1523-8. (Pubitemid 27187611)
34. *0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc Natl Acad Sci USA 1997; 94(12):6313-8. (Pubitemid 27270681)
35. Rudolph MG, Luz JG, Wilson IA. Structural and thermodynamic correlates of T-cell signaling. Annu Rev Biophys Biomol Struct 2002; 31:121-49. (Pubitemid 34666828)
36. *2705. J Exp Med 1996, 184(4):1585-90. (Pubitemid 26354718)
37. *2705 by specific natural killer cells. J Immunol 1996; 157(8):3350-6. (Pubitemid 126449146)
38. *2705. Eur J Immunol 2005, 35(2):341-51. (Pubitemid 40331309)
39. Sims AM, Wordsworth BP, Brown MA. Genetic susceptibility to ankylosing spondylitis. Curr Mol Med 2004, 4(1):13-20. (Pubitemid 38279427)
40. Turner MJ, Sowders DP, DeLay ML et al. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J Immunol 2005; 175(4):2438-48. (Pubitemid 41113854)
41. Gonzalez-Roces S, Alvarez MV, Gonzalez S et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 1997; 49(2):116-23. (Pubitemid 27084693)
42. García-Fernández S, Gonzalez S, Miña Blanco A et al. New insights regarding HLA-B27 diversity in the asian population. Tissue Antigens 2001; 58(4) :259-62. (Pubitemid 34015430)
43. Lopez de Castro JA, Alvarez I, Marcilla M et al. HLA-B27: A registry of constitutive peptide ligands. Tissue Antigens 2004; 63(5):424-45. (Pubitemid 38648208)
44. López-Larrea C, Sujirachato K, Mehra NK et al. HLA-B27 subtypes in asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 1995; 45(3):169-76.
45. Paladini F, Taccari E, Fiorillo MT et al. Distribution of HLA-B27 subtypes in sardinia and continental Italy and their association with spondylarthropathies. Arthritis Rheum 2005; 52(10):3319-21. (Pubitemid 41447118)
46. Reveille JK, Ball EJ, Khan MA. HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr Opin Rheumarol 2001; 13(4):265-72. (Pubitemid 32831816)
47. Said-Nahal R, Miceli-Richard C, Gautreau C et al. The role of HLA genes in familial spondyloarchroparhy: a comprehensive study of 70 multiplex families. Ann Rheum Dis 2002; 61(3):201-6. (Pubitemid 34177748)
48. Young Ho Lee, Young Hee Rho, Seong Jae Choi et al. Ankylosing spondylitis susceptibility loci defined by genome-search meta-analysis. J Hum Genet 2005; 50:453-459. (Pubitemid 41483331)
49. Zhang G, Luo J, Bruckel J et al. Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis and Rheumatism 2004; 50:2246-2254. (Pubitemid 38924403)
50. Laval SH, Timms A, Edwards S et al. Whole-genome screening in ankylosing spondylitis: evidence of nonMHC genetic-susceptibility loci. AmJ Hum Genet 2001b; 68:918-926 . (Pubitemid 32289738)
51. Gumperz JE, Litwin V, Phillips JH et al. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB 1, a putative HLA recepcor. J Exp Med 1995; 181(3):1133-44.
52. Martin MP, Gao X, Lee JH et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002; 31(4):429-34. (Pubitemid 35154456)
53. Gillespie GM, Bashirova A, Dong T et al. Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T-cell epitopes. AIDS Res Hum Retroviruses 2007; 23(3):451-5. (Pubitemid 46608565)
54. Lopez-Larrea C, Blanco-Gelaz MA, Torre-Alonso JC et al. Contribution of KIR3DL1/3DSI to ankylosing spondylitis in human leukocyte antigen-B27 caucasian populations. Arthritis Res Ther 2006; 8(4) :RI01.
55. Díaz-Peña R, Blanco-Gelaz MA, Suárez-Álvarez B et al. Activating KIR genes are associated with Ankylosing spondylit is in asian populations. In press. Human Immunology.
56. Litwin V, Gurnperz J, Parham P et al. NKB1: A natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.J Exp Med 1994; 180(2):537-43. (Pubitemid 24224130)
57. Gumperz JE, Valiance NM, Parham P et al. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major hisrocomparibililty complex haplotype. J Exp Med 1996; 183(4):1817-27.
58. Martin MP, Qi Y, Gao X et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007; 39(6):733-40. (Pubitemid 46848586)
59. Appel H, Kuon W, Kuhne M et al. The solvent-inaccessible Cys67 residue of HLA-B27 contributes to T-cell recognition of HLA-B27/peptide complexes. J Immunol 2004; 173(11):6564-73. (Pubitemid 39541039)
60. Allen RL, Raine T, Haude A et al. Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 srructures. J Immunol 2001; 167(10):5543-7. (Pubitemid 33062742)
61. Kollnberger S, Bird L, Sun MY et al. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum 2002; 46(11):2972-82. (Pubitemid 35315891)
62. Nair RP, Stuart PE, Nistor I et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 2006; 78(5):827-51.
63. Marcin MP, Nelson G, Lee JH et al. Cutting edge: Susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 2002; 169(6):2818-22. (Pubitemid 35013118)
64. Nelson GW, Marcin MP, Gladman D et al. Cutting edge: Heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 2004; 173(7):4273-6. (Pubitemid 39280654)
65. Vilches C, de Pablo R, Herrero MJ et al. HLA-B73: An atypical HLA-B molecule carrying a Bw6-epitope motif variant and a B pocket identical to HLA-B27. Immunogenetics 1994; 40(2):166. (Pubitemid 24193972)
66. Thananchai H, Gillespie G, Marcin MP et al. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol 2007; 178(1):33-7. (Pubitemid 46033585)
67. Wei JC, Tsai WC, Lin HS et al. HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients. Rheumatology (Oxford) 2004; 43(7):839-42. (Pubitemid 38996956)
68. Yamaguchi A, Tsuchiya N, Mitsui H et al. Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in japanese patients. Evidence for a role of the peptide-anchoring B pocket. Arthritis Rheum 1995; 38(11):1672-7.
69. *1403 in a west african population. Arthritis Rheum 2002; 46(11):2968-71. (Pubitemid 35315890)
70. Chan AT, Kollnberger SD, Wedderburn LR et al. Immunoglobulin-like receptor KIR3DL2 in spondylarthritis. Arthritis Rheum 2005; 52(11):3586-95.
71. Yen JH, Moore BE, Nakajima T et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid artritis. J Exp Med 2001; 193(10):1159-67. (Pubitemid 32488368)
72. Majorczyk E, Pawlik A, Łuszczek W et al. Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis. Genes Immun 2007; 8(8):678-83. (Pubitemid 350238438)
73. Yen JH, Lin CH, Tsai WC et al. Killer cell immunoglobulin-like receptor gene's repertoire in rheumatoid arthritis. Scand J Rheumarol 2006; 35(2):124-7.
74. Momot T, Koch S, Hunzelmann N et al. Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 2004; 50(5):1561-5. (Pubitemid 38608078)
75. Takeno M, Shimoyama Y, Kashiwakura J et al. Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behcer's disease. Rheurnatol Int 2004; 24(4):212-6. (Pubitemid 39062491)
76. Łuszczek W, Mańczak M, Cislo Met al. Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. Hum Immunol 2004; 65(7):758-66. (Pubitemid 39061175)
77. Suzuki Y, Hamamoto Y, Ogasawara Y et al. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. J Invest Dermatol2004; 122(5):1133-6.
78. van der Slik AR, Koeleman BP, Verduijn W et al. KIR in type 1 diabetes: Disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 2003 ; 52(10):2639-42. (Pubitemid 37210556)